Price data is not available
IGC Pharma Inc
IGCAMEX
IGC Pharma Earnings & Forecasts
IGC Pharma (IGC) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
IGC Pharma Guidance
Recent Earnings Results
| Metric | Q2 '27 | Q1 '27 | Q3 '26 | Q2 '26 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.02 | — | $-0.02 | $-0.02 |
| Actual | $-0.03 | $-0.02 | $-0.01 | $-0.02 |
| Surprise | -50.0% | — | +50.0% | 0.00% |
| Revenue | ||||
| Estimate | $160000 | — | $392100 | $353800 |
| Actual | $265000 | $317000 | $213000 | $191000 |
| Surprise | +65.6% | — | -45.7% | -46.0% |
Analyst Estimates — Forward PeriodsSource: Wall Street consensus
| Metric | Q3 '27E | Q4 '27E | Q1 '28E |
|---|---|---|---|
| Earnings Per Share (Non-GAAP) | |||
| Consensus | $-0.02 | $-0.02 | $-0.02 |
| Revenue | |||
| Consensus | $100000 | $280000 | — |
